Table 2.
Basic demographics, disease and treatment characteristics of the survivors included in phase 1b
| Survivors | Phase 1a | Phase 1b | |
|---|---|---|---|
| N = 117 | Total N = 458 | Subsample N = 386a | |
| Age | |||
| Mean ± SD (years) | 57 (13.6) | 59 (13.8) | 59 (13.7) |
| Sex (%) | |||
| male | 58 (50%) | 246 (54%) | 207 (54%) |
| Partner statusb | |||
| in relationship | 90 | 367 | 313 |
| widower/ divorced/ separated | 9 | 61 | 49 |
| single | 14 | 50 | 43 |
| Education (%) | |||
| none or primary school only | 15 (13%) | 59 (13%) | 47 (12%) |
| high school | 46 (39%) | 167 (36%) | 140 (36%) |
| college or university | 53 (45%) | 222 (48%) | 190 (49%) |
| missing | 3 (3%) | 10 (2%) | 9 (2%) |
| Work status (%) | |||
| working | 59 (50%) | 205 (45%) | 180 (47%) |
| retired | 43 (37%) | 185 (40%) | 157 (41%) |
| unemployed | 4 (3%) | 24 (5%) | 17 (4%) |
| homemaker | 4 (3%) | 22 (5%) | 17 (4%) |
| disabled | 5 (4%) | 10 (2%) | 7 (2%) |
| other or missing | 2 (2%) | 12 (2%) | 10 (3%) |
| Disease recurrence (%) | 11 (9%) | 75 (16%) | 66 (17%) |
| Tumor stagec (%) | |||
| stage I | 19 (16%) | 101 (23%) | 88 (24%) |
| stage II | 45 (38%) | 131 (30%) | 108 (28%) |
| stage III | 29 (25%) | 113 (25%) | 95 (25%) |
| stage IV | 3 (3%) | 40 (9%) | 34 (9%) |
| stage unknown | 13 (11%) | 47 (11%) | 40 (10%) |
| no stage determined | 8 (7%) | ||
| Time since completing primary treatment | |||
| Mean (SD) (years) | – | 4.2 (4.0) | 4.8 (4.0) |
| Time since completing last treatment | |||
| Mean (SD) (years) | – | 3.6 (3.2) | 4.4 (3.2) |
| Therapyb | |||
| surgery | 98 | 342 | 326 |
| chemotherapy | 77 | 254 | 222 |
| radiotherapy | 54 | 238 | 209 |
| hormonal therapy | 15 | 49 | 48 |
| monoclonal antibodies | 2 | 21 | 18 |
| cell transplantation | 6 | 6 | |
| active surveillance | 7 | 66 | 59 |
| current maintenance therapy | 8 | 61 | 47 |
Percentages are given in the cases that categories are mutually exclusive
N number, SD Standard deviation
asubsample of phase 1b that consists of the survivors who are at least 1 year after treatment completion
bcategories are not mutual exclusive, e.g. one can be a widower and have a new relationship
cfor glioma survivors in Phase 1b tumor grading was used, we included per tumor grade: grade 1: 2 survivors; grade 2: 8 survivors; grade 3: 14 survivors; grade 4: 1 survivor